# Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

> **NCT03257462** · PHASE2 · COMPLETED · sponsor: **Spruce Biosciences** · enrollment: 24 (actual)

## Conditions studied

- Congenital Adrenal Hyperplasia
- CAH - Congenital Adrenal Hyperplasia

## Interventions

- **DRUG:** SPR001

## Key facts

- **NCT ID:** NCT03257462
- **Lead sponsor:** Spruce Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-12
- **Primary completion:** 2019-03-02
- **Final completion:** 2019-03-29
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03257462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03257462, "Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03257462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*